1.
Tran MT, Delate T, Bachmann S. Patient factors associated with hemoglobin A1C change with pioglitazone as adjunctive therapy in type 2 Diabetes Mellitus. Pharm Pract (Granada) [Internet]. 2008 Jun. 17 [cited 2022 Aug. 16];6(2):79-87. Available from: https://pharmacypractice.org/index.php/pp/article/view/220